BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 753287)

  • 1. [Effects of increasing doses of tolbutamide on insulin secretion in normal and diabetic subjects].
    Ragonese F; Carducci Artenisio A; Alibrando A; Martelli G; Forte F; Consolo F
    Boll Soc Ital Biol Sper; 1978 Oct; 54(20):1978-84. PubMed ID: 753287
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stimulation of insulin secretion by tolbutamide. Studies on experimental diabetes].
    Ammon HP
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1675-6. PubMed ID: 4150009
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 5. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood insulin and diabetes. I. Method of study--normal subjects--diabetic disease].
    Duprey J; Lubetzki J
    Pathol Biol (Paris); 1971 Mar; 19(5):311-31. PubMed ID: 4929994
    [No Abstract]   [Full Text] [Related]  

  • 7. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 8. [The significance of insulin secretion in the pathogenesis of diabetes mellitus].
    Verlohren HJ; Lohmann D
    Z Gesamte Inn Med; 1981 Feb; 36(4):254-6. PubMed ID: 7013305
    [No Abstract]   [Full Text] [Related]  

  • 9. [Types of insulin secretion in diabetes mellitus].
    Verlohren HJ; Vrahimis J; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1975; 35(4):183-90. PubMed ID: 1227812
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of exocrine and endocrine pancreatic functions].
    Pohl A; Kade R; Heilmann W; Verlohren HJ
    Z Gesamte Inn Med; 1977 Feb; 32(3):48 contd. PubMed ID: 855393
    [No Abstract]   [Full Text] [Related]  

  • 11. Offspring of two diabetic parents: differential serum insulin responses to intravenous glucose and tolbutamide.
    Rojas L; Soeldner JS; Gleason RE; Kahn CB; Marble A
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1569-79. PubMed ID: 4899852
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin secretion after administration of sulfonylurea in normal and diabetic subjects].
    Okajima J
    Nihon Naibunpi Gakkai Zasshi; 1974 Jan; 50(1):19-29. PubMed ID: 4210027
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute insulin response to tolbutamide of pancreatic beta-cell].
    Emoto M; Nishizawa Y
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():319-24. PubMed ID: 12355766
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T; Lauridsen UB; Madsen SN; Mogensen P
    Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
    [No Abstract]   [Full Text] [Related]  

  • 16. [A method of studying insulin secretion in humans: the glucose stimulation test, followed by tolbutamide].
    Vague P; Ramahandridona G; Vialettes B
    Nouv Presse Med; 1976 Dec; 5(4):3001-4. PubMed ID: 794823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin secretion during primo-insulin therapy of diabetes resistant to oral drugs].
    Orsetti A; Mirouze J
    Journ Annu Diabetol Hotel Dieu; 1969; 10():311-8. PubMed ID: 5376990
    [No Abstract]   [Full Text] [Related]  

  • 18. The stimulatory effect on insulin secretion in long-term tolbutamide treatment. Immunological determinations of urinary- and serum insulin.
    Johansen K; Orskov H
    Acta Endocrinol (Copenh); 1972 Dec; 71(4):709-15. PubMed ID: 4678208
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin secretion in normal and diabetic individuals.
    Kipnis DM
    Adv Intern Med; 1970; 16():103-34. PubMed ID: 4916357
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of tolbutamide-mediated insulin release in adult onset diabetics by methysergide maleate.
    Baldridge JA; Quickel KE; Feldman JM; Lebovitz HE
    Diabetes; 1974 Jan; 23(1):21-4. PubMed ID: 4588670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.